Search research articles
Contact Us
Filters
Showing results (101-110 of 161) with videos related to
Page
of 17
Sort By:
Journal of Medical Virology
|
April 20, 2011
Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy
Takahiro Azakami, C Nelson Hayes, Hitomi Sezaki, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 27, 2021
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
Yasutoshi Fujii, Atsushi Ono, C Nelson Hayes, et al.
Journal of Gastroenterology
|
January 20, 2011
Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
Kazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 3, 2010
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
Kazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.
Journal of Hepatology
|
December 15, 2010
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo
Hiromi Abe, Michio Imamura, Nobuhiko Hiraga, et al.
Journal of Medical Virology
|
October 5, 2019
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy
Yuhei Saito, Michio Imamura, Takuro Uchida, et al.
Antimicrobial Agents and Chemotherapy
|
April 5, 2017
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus
Masataka Tsuge, Takuro Uchida, Nobuhiko Hiraga, et al.
The Journal of General Virology
|
June 20, 2018
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure
Yuji Teraoka, Takuro Uchida, Michio Imamura, et al.
Journal of Gastroenterology and Hepatology
|
August 6, 2014
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis
Satoe Yokoyama, Yoshiiku Kawakami, Michio Imamura, et al.
Antiviral Therapy
|
December 15, 2010
Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy
Shosuke Kitamura, Masataka Tsuge, Tsuyoshi Hatakeyama, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 161) with videos related to
Sort By:
Page
of 17
Journal of Medical Virology
|
April 20, 2011
Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy
Takahiro Azakami, C Nelson Hayes, Hitomi Sezaki, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 27, 2021
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
Yasutoshi Fujii, Atsushi Ono, C Nelson Hayes, et al.
Journal of Gastroenterology
|
January 20, 2011
Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
Kazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 3, 2010
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
Kazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.
Journal of Hepatology
|
December 15, 2010
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo
Hiromi Abe, Michio Imamura, Nobuhiko Hiraga, et al.
Journal of Medical Virology
|
October 5, 2019
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy
Yuhei Saito, Michio Imamura, Takuro Uchida, et al.
Antimicrobial Agents and Chemotherapy
|
April 5, 2017
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus
Masataka Tsuge, Takuro Uchida, Nobuhiko Hiraga, et al.
The Journal of General Virology
|
June 20, 2018
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure
Yuji Teraoka, Takuro Uchida, Michio Imamura, et al.
Journal of Gastroenterology and Hepatology
|
August 6, 2014
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis
Satoe Yokoyama, Yoshiiku Kawakami, Michio Imamura, et al.
Antiviral Therapy
|
December 15, 2010
Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy
Shosuke Kitamura, Masataka Tsuge, Tsuyoshi Hatakeyama, et al.
Page
of 17